OBSEVA SA

ACTIVE

Switzerlandwww.obseva.comPublic15 employeesEstablished: 2012-01-01

Clinical Trials

25 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2012

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

75.0%

Phase 2

11.1%

Phase 3

11.1%

Trial Status Distribution

Active, not recruiting

69.4%

Completed

22.2%

Terminated

2.8%

Unknown

2.8%

Withdrawn

2.8%

Clinical Trials

Trials sponsored by this organization (36)

Safety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic Function

Phase 1

Completed

interventional

May 201924 participants

Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function

Phase 1

Completed

interventional

May 201933 participants

Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF

Phase 3

Completed

interventional

Jan 2019820 participants

Placebo-controlled study to assess nolasiban to increase pregnancy rates in women undergoing IVF

Phase 1

Active, not recruiting

Dec 2018820 participants

Placebo-controlled study to assess nolasiban to increase pregnancy rates in women undergoing IVF

Phase 1

Active, not recruiting

Nov 2018820 participants

Placebo-controlled study to assess nolasiban to increase pregnancy rates in women undergoing IVF

Phase 1

Active, not recruiting

Sep 2018820 participants

Placebo-controlled study to assess nolasiban to increase pregnancy rates in women undergoing IVF

Phase 1

Active, not recruiting

Sep 2018820 participants

A pilot study to assess the efficacy and safety of OBE2109 in subjects with rectovaginal endometriosis.

Phase 1

Active, not recruiting

Feb 20189 participants

Page 1 of 5

Approvals

No approval data available

News

No news articles found

Back to Organizations